CMPS Trend Reversal?CMPS has been struggling to gain the 4.80 Resistance Level on the higher timeframes, but has recently closed above this level and has since confirmed support at the 4.00 level, making long positions reasonable to take. Nothing is guaranteed, but I have bought 100 shares at 4.42 based off this analys
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.30 USD
−155.19 M USD
0.00 USD
64.17 M
About COMPASS Pathways Plc - American Depository Shares
Sector
Industry
CEO
Kabir Kumar Nath
Website
Headquarters
London
Founded
2020
FIGI
BBG00X0VY2N1
Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
CMPS - one more move up before big selloffBullish shark completed and bearish 5-0 potential formation
Trendlines and line breaks all support the move. Anticipating a false breakout of the falling wedge before big selloff and new all time lows.
Long term I like the idea of this. People will be moving away from typical medicine and will wa
Compass Pathways Wave Analysis: Huge Moves aheadCompass Pathways appears to have completed an impulsive 5-wave move to the upside, signaling significant strength in its recent price action. The peak of this move, reaching $12.75, is notably identified as the B wave within an extended flat correction, potentially forming part of a larger 5-wave pa
CMPS is starting to raise its head, pay attention!!The stock has positive momentum, breaking out a long shuffle
Caution is required... According to the SEC, there have recently been sales by insiders.
Oscillators in positive territory
$12.3 critical level (Note that the volume supports the resistance breakout)
You will find target price (first) in t
Follow Your Compass $CMPSThe next hype narrative after crypto has its bull run and seems “tapped out” will be psychedelics having a clinical use case and the runway for approval lines up perfectly. Compass has established itself as the best positioned player in the game and the shares have never been more reasonable. I am a
Psilocybin for Depression Stage 3 Research $CMPS5 minutes ago
Breakout Divergence Formation. Bottom Forming Around $6/share.
Context:
Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalizat
Psilocybin for Depression Stage 3 Research $CMPSBreakout Divergence Formation. Bottom Forming Around $6/share.
Context:
Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalization. Psilocybi
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.